Academic literature on the topic 'Arpitā'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Arpitā.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Arpitā"

1

Patel, Jeetvan, Amrita Sawhney, Clare Byrne, Jackson Tang, and Channing Yu. "Real-world treatment patterns and progression-free survival among patients with metastatic castration-resistant prostate cancer: Examining the benefits of sequential androgen receptor pathway inhibitor use." Journal of Clinical Oncology 41, no. 6_suppl (2023): 64. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.64.

Full text
Abstract:
64 Background: Numerous treatments with different mechanisms of action are approved for metastatic castration-resistant prostate cancer (mCRPC), but real-world studies increasingly indicate that androgen receptor pathway inhibitors (ARPIs) are the most common treatment choice at both first- (1L) and second-line (2L). Nonetheless, robust evidence on the clinical effectiveness of ARPIs when used sequentially is lacking. The aim of this study was to examine the real-world treatment patterns and associated progression-free survival (PFS) among patients with mCRPC in the United States (US). Methods
APA, Harvard, Vancouver, ISO, and other styles
2

Fisher, David John, Claire Louise Vale, Larysa H. Rydzewska, et al. "Which patients with metastatic hormone-sensitive prostate cancer (mHSPC) benefit more from androgen receptor pathway inhibitors (ARPIs)? STOPCAP meta-analyses of individual participant data (IPD)." Journal of Clinical Oncology 43, no. 5_suppl (2025): 20. https://doi.org/10.1200/jco.2025.43.5_suppl.20.

Full text
Abstract:
20 Background: Clinical features of people with mHSPC may affect their outcomes from the addition of ARPIs to androgen deprivation therapy (ADT). The STOPCAP Collaboration is seeking IPD to reliably investigate potential ARPI effect modifiers and determine who benefits more from an ARPI vs docetaxel plus ADT doublet. Methods: Full methods are in registered protocols (CRD42023431331; CRD4202540066). We sought IPD for completed trials examining effects of ARPIs for mHSPC. Initially, we examined ARPI effects using intention-to-treat, two-stage, common-effect meta-analysis of hazard ratios (HRs),
APA, Harvard, Vancouver, ISO, and other styles
3

Litvin, Valentyn, Armen G. Aprikian, and Alice Dragomir. "Cost-Effectiveness Analysis of Contemporary Advanced Prostate Cancer Treatment Sequences." Current Oncology 32, no. 4 (2025): 240. https://doi.org/10.3390/curroncol32040240.

Full text
Abstract:
There has been a proliferation of novel treatments for the management of advanced prostate cancer (PCa), including androgen receptor pathway inhibitors (ARPI). Although there are health economic analyses of novel PCa treatments, such as ARPIs for specific health states, there is a lack of sequential analyses. Our paper aims to fill this gap. We developed a Monte Carlo Markov model to simulate the management of advanced PCa to end-of-life. We modeled patients who begin in metastatic and nonmetastatic castration-sensitive PCa (mCSPC and nmCSPC), with risk stratification for mCSPC, progressing to
APA, Harvard, Vancouver, ISO, and other styles
4

Yazdanpanah, Omid, Jeremie Calais, Kim N. Chi, et al. "Efficacy of 177 Lu-PSMA-617 with or without ARPIs for the treatment of mCRPC: VISION secondary analysis." Journal of Clinical Oncology 43, no. 5_suppl (2025): 121. https://doi.org/10.1200/jco.2025.43.5_suppl.121.

Full text
Abstract:
121 Background: In the Phase 3 VISION trial, treatment with the prostate-specific membrane antigen (PSMA)-targeted radioligand therapy [ 177 Lu]Lu-PSMA-617 ( 177 Lu-PSMA-617) + protocol-permitted standard of care (SoC) significantly improved median radiographic progression-free survival (rPFS; 8.7 vs 3.4 months [mo]) and overall survival (OS; 15.3 vs 11.3 mo) in patients with metastatic castration-resistant prostate cancer (mCRPC) vs SoC alone. However, it is unclear how the addition of androgen receptor pathway inhibitors (ARPIs) affected 177 Lu-PSMA-617 treatment outcomes. Here we compared t
APA, Harvard, Vancouver, ISO, and other styles
5

Bakkal Temi, Yasemin, Büşra Yılmaz Tuğan, İlkay Çıtakkul, et al. "Structural Retinal and Optic Nerve Changes in Prostate Cancer Patients Receiving Androgen Receptor Pathway Inhibitors: An OCT-Based In Vivo Analysis." Diagnostics 15, no. 13 (2025): 1682. https://doi.org/10.3390/diagnostics15131682.

Full text
Abstract:
Objective: To conduct a comparative analysis of layer-by-layer macular thickness, peripapillary retinal nerve fiber layer (pRNFL), and minimum rim width (MRW) between the eyes of patients with prostate cancer undergoing treatment with androgen receptor pathway inhibitors (ARPIs) and those of age- and sex-matched healthy controls, with the aim of assessing the potential effects of ARPIs on retinal structure. Methods: In this prospective cross-sectional study, 80 eyes of 80 patients with ARPI-treated metastatic prostate cancer and 80 eyes of 80 age-matched healthy controls were evaluated using H
APA, Harvard, Vancouver, ISO, and other styles
6

Schoen, Martin W., Ruth Douglas Etzioni, Suhong Luo, et al. "Comparison of outcomes with docetaxel or ARPI combination therapy for metastatic hormone-sensitive prostate cancer (mHSPC) by volume of disease." Journal of Clinical Oncology 42, no. 16_suppl (2024): 5092. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.5092.

Full text
Abstract:
5092 Background: Combination therapy has improved treatment of metastatic hormone sensitive prostate cancer (mHSPC). Doublets include androgen deprivation therapy (ADT) plus docetaxel (DOC) or the androgen receptor pathway inhibitors (ARPIs) abiraterone, enzalutamide, apalutamide, or darolutamide. There have been no large clinical trials that compare DOC to ARPIs in mHSPC. This study evaluates overall survival and time to castration-resistance in patients with de novo (synchronous) mHSPC in the Veterans Health Administration treated with combination therapy. Methods: Veterans were identified w
APA, Harvard, Vancouver, ISO, and other styles
7

Kolinsky, Michael Paul, Dylan E. O'Sullivan, Devon J. Boyne, Darren R. Brenner, Simran Shokar, and Winson Y. Cheung. "A real-world observational study characterizing patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) treated with or without androgen receptor pathway inhibitors (ARPIs)." Journal of Clinical Oncology 42, no. 4_suppl (2024): 59. http://dx.doi.org/10.1200/jco.2024.42.4_suppl.59.

Full text
Abstract:
59 Background: mCSPC treatment is rapidly evolving with androgen deprivation therapy (ADT) plus ARPIs viewed as the standard of care for most pts. Data are needed to understand the real-world characteristics and treatment patterns of mCSPC (PC) pts in this dynamic field. This study aimed to define clinical features of mCSPC pts, estimate the proportion of pts receiving ARPIs, and evaluate clinical and demographic features associated with ARPI use. Methods: This retrospective cohort study used data from electronic health records and administrative databases in the province of Alberta, Canada. A
APA, Harvard, Vancouver, ISO, and other styles
8

Raval, Amit D., Guifang Chen, Matthew J. Korn, Andreas Bernthaler, Niculae Constantinovici, and Stephen J. Freedland. "Real-world treatment patterns and survival in men with metastatic castration-resistant prostate cancer (mCRPC) who previously progressed from metastatic hormone-sensitive prostate cancer (mHSPC) between 2020 to 2023 in the United States." Journal of Clinical Oncology 43, no. 5_suppl (2025): 99. https://doi.org/10.1200/jco.2025.43.5_suppl.99.

Full text
Abstract:
99 Background: While androgen deprivation therapy (ADT) is a backbone for managing mHSPC, therapies initially approved for mCRPC, such as androgen receptor pathways inhibitors like abiraterone (ABI) and non-ABI ARPIs ( enzalutamide, apalutamide, darolutamide), and/or docetaxel, are now guideline-recommended for use in mHSPC. Evidence on how this shift in mHSPC management affects current mCRPC treatment patterns and survival is lacking. Methods: A retrospective cohort of men treated for mCRPC between 2020-2023 was identified in the ConcertAI NLP360 oncology electronic medical records (EMR) data
APA, Harvard, Vancouver, ISO, and other styles
9

Muraoka, Hiromi, Kazuhisa Minamiguchi, Akihiro Hashimoto, Hiroshi Sootome, and Shuichi Ohkubo. "Abstract 4437: Pimitespib (TAS-116), an HSP90 inhibitor, overcomes resistance to androgen receptor pathway inhibitors in prostate cancer by simultaneously targeting several key resistance mechanisms." Cancer Research 85, no. 8_Supplement_1 (2025): 4437. https://doi.org/10.1158/1538-7445.am2025-4437.

Full text
Abstract:
Abstract Background: Resistance to androgen receptor pathway inhibitors (ARPIs) poses a significant challenge in the treatment of metastatic castration-resistant prostate cancer (mCRPC). Key mechanisms driving ARPI resistance include androgen receptor (AR) overexpression, AR mutations, AR splice variants such as AR-V7, alternative glucocorticoid receptor (GR) signaling, and activation of the AKT pathway. Heat shock protein 90 (HSP90), a molecular chaperone essential for stabilizing several of the key proteins involved in these resistance-related mechanisms, has emerged as a compelling therapeu
APA, Harvard, Vancouver, ISO, and other styles
10

Raval, Amit D., Orsolya Lunacsek, Matthew J. Korn, Natasha Littleton, Niculae Constantinovici, and Daniel J. George. "Real-world intensification beyond androgen deprivation therapy (ADT) in metastatic hormone sensitive prostate cancer (mHSPC) in the United States 2017-2023: An administrative claims database study." Journal of Clinical Oncology 42, no. 16_suppl (2024): e17082-e17082. http://dx.doi.org/10.1200/jco.2024.42.16_suppl.e17082.

Full text
Abstract:
e17082 Background: Severalguidelines recommended the use of androgen receptor pathway inhibitors (ARPIs) and/or docetaxel along with ADT for mHSPC based on improved clinical outcomes demonstrated in clinical trials. Given the evolving treatment landscape since 2016, there is a need to understand the translation of clinical evidence and guidelines into clinical practice. Therefore, we examined the use of, and factors associated with intensification beyond ADT in men with mHSPC. Methods: A retrospective cohort of men treated for mHSPC was selected from private insurance claims of the Komodo Rese
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Arpitā"

1

Khanna, Arpita [Verfasser]. "The Oil Curse Revisited : Ownership Matters / Arpita Khanna." Konstanz : Bibliothek der Universität Konstanz, 2017. http://d-nb.info/1136571175/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sharma, Arpit Verfasser], Joost-Pieter [Akademischer Betreuer] [Katoen, and Holger [Akademischer Betreuer] Hermanns. "Reduction Techniques for Nondeterministic and Probabilistic Systems / Arpit Sharma ; Joost-Pieter Katoen, Holger Hermanns." Aachen : Universitätsbibliothek der RWTH Aachen, 2015. http://d-nb.info/1159379912/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sharma, Arpit [Verfasser], Joost-Pieter [Akademischer Betreuer] Katoen, and Holger [Akademischer Betreuer] Hermanns. "Reduction Techniques for Nondeterministic and Probabilistic Systems / Arpit Sharma ; Joost-Pieter Katoen, Holger Hermanns." Aachen : Universitätsbibliothek der RWTH Aachen, 2015. http://d-nb.info/1159379912/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Choudhary, Arpita [Verfasser], Artie Prof Gutachter] Hatzes, Sebastian [Gutachter] [Wolf, and Henrik [Gutachter] Beuther. "Young star V1331 Cygni takes centre stage / Arpita Choudhary ; Gutachter: Artie Hatzes, Sebastian Wolf, Henrik Beuther." Jena : Friedrich-Schiller-Universität Jena, 2016. http://d-nb.info/1177611317/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Roy, Choudhury Arpita Verfasser], Dieter [Akademischer Betreuer] Häussinger, and Dieter [Akademischer Betreuer] [Willbold. "Untersuchung von kompatible Soluten induzierter Stabilisation von Membranproteinen mittels Rasterkraftspektroskopie. / Arpita Roy Choudhury. Gutachter: Dieter Häussinger ; Dieter Willbold." Düsseldorf : Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf, 2013. http://d-nb.info/1038786045/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kulkarni, Arpita [Verfasser], and Adrian [Akademischer Betreuer] Streit. "The Reproductive Biology of Strongyloides Nematodes - Sex Determination, Chromatin Diminution and Germline Organization / Arpita Kulkarni ; Betreuer: Adrian Streit." Tübingen : Universitätsbibliothek Tübingen, 2015. http://d-nb.info/1163461946/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chemeris, Angelina. "Régulation du suppresseur d'invasion Arpin par les Tankyrases." Thesis, Université Paris-Saclay (ComUE), 2018. http://www.theses.fr/2018SACLX073.

Full text
Abstract:
Le complexe Arp2/3, conservé sur le plan évolutif, joue un rôle central dans la nucléation d’actine branchée, qui entraîne la migration cellulaire, l’endocytose et d’autres processus cellulaire. Récemment, une petite protéine, Arpin, qui inhibe le complexe Arp2/3 au front du lamellipode a été découverte et caractérisée. Sur sa partie C-terminale, Arpin possède un motif acide (A), qui est homologue au motif A des différents NPF (Nucleation Promoting Factor). Il a été prédit qu’Arpin peut se lier à deux sites de liaison au complexe Arp2/3, similaire aux domaines VCA des NPF. Ici, nous utilisons
APA, Harvard, Vancouver, ISO, and other styles
8

Das, Arpita [Verfasser], Uwe [Akademischer Betreuer] Nehls, Uwe [Gutachter] Nehls, and Barbara [Gutachter] Reinhold-Hurek. "Ectomycorrhiza Development : Investigation of Selected Ectomycorrhiza Induced Poplar Genes / Arpita Das ; Gutachter: Uwe Nehls, Barbara Reinhold-Hurek ; Betreuer: Uwe Nehls." Bremen : Staats- und Universitätsbibliothek Bremen, 2018. http://d-nb.info/1169299121/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Kundu, Arpita [Verfasser], Donat [Gutachter] Kögel, and Jochen [Gutachter] Klein. "The role of the amyloid precursor protein (APP) in protein homeostasis and neuroprotection / Arpita Kundu ; Gutachter: Donat Kögel, Jochen Klein." Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2017. http://d-nb.info/114052576X/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Arpin-Pont, Jérémy. "Méthode de détermination des incertitudes de mesures par jauges de déformation." Mémoire, École de technologie supérieure, 2012. http://espace.etsmtl.ca/1120/1/ARPIN%2DPONT_J%C3%A9r%C3%A9my.pdf.

Full text
Abstract:
Cette recherche a pour but d’estimer les incertitudes de mesures de déformations obtenues avec des jauges de déformation. Une Méthode Numérique d’Évaluation des Incertitudes de Mesure (MNEIM) est proposée et permet d’estimer une étendue des déformations dans laquelle les mesures doivent se situer statistiquement, en prenant en compte les erreurs et incertitudes de mesures engendrées par les caractéristiques technologiques de la jauge et son positionnement. Pour cela, la MNEIM se base sur les champs de déplacements obtenus par analyses Éléments Finis (ÉF) de la pièce étudiée. Par la suite, cett
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Arpitā"

1

Siṃha, Arpitā. ["For Anjum". Nature Morte and Bose Pacia Modern in association with Tulika Books, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

author, Ananth Deepak, and Vadehra Art Gallery, eds. Arpita Singh. Penguin Studio, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Simha, Arpita. Arpita Singh 92. Center for Contemporary Art, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pietra, Vincenzo La. Arpino. Manfredi edizioni, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

interviewer, Sinha Gayatri author, ed. Arpita Singh: Works on paper. Vadehra Art Gallery, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ānachārauddina, Sikadāra Moḥ, ed. Arpita o parityakta sampatti āina. Selimā Ānajuārā, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Veneziano, Gian Mario. Giovanni Arpino. Mursia, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Singh, Arpita. Arpita Singh: 5 mars-11 mai 1986. Centre Georges Pompidou, Musée national d'art moderne, Galeries contemporaines, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Strati, Saverio. L' arpia. Marco editore, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

1909-, Mahāpātra Śarmā Śrīdhara, and Mahāpātra Abhirāma, eds. Smr̥ti-barttikā: Svargata Śrīdhara Mahāpātra Śarmāṅku arpita śraddhāñjaḷi. Granthamandira, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Arpitā"

1

Corno, Fulvio, Gianluca Cumani, Matteo Sonza Reorda, and Giovanni Squillero. "ARPIA: A High-Level Evolutionary Test Signal Generator." In Lecture Notes in Computer Science. Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/3-540-45365-2_31.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kasstan, Jonathan. "New Speakers and Language Revitalisation: Arpitan and Community (Re)formation." In French Language Policies and the Revitalisation of Regional Languages in the 21st Century. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-95939-9_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Shigemasa, Eiji, and Nobuhiro Kosugi. "Molecular Inner-Shell Spectroscopy. ARPIS Technique and its Applications." In Advances in Chemical Physics. John Wiley & Sons, Inc., 2011. http://dx.doi.org/10.1002/9781118135242.ch2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Leone, Marcella, and Priscilla Munzi. "Mourir à Arpi (Pouilles, Italie du Sud) : typo-chronologie des sépultures à inhumation entre le vie et le ier siècle avant J.-C." In Rencontre autour des typo-chronologies des tombes à inhumation. Fédération pour l’édition de la Revue archéologique du Centre de la France, 2022. http://dx.doi.org/10.4000/12pfn.

Full text
Abstract:
Le site daunien d’Arpi est implanté dans la plaine alluviale du Tavoliere des Pouilles. Les premières attestations d’une occupation remontent à l’âge du Fer, mais c’est surtout à partir du ive s. que l’agglomération prend progressivement de l’importance. Le site est défini par un agger qui renferme une superficie de 1 000 ha et protège une aire destinée à accueillir non seulement l’habitat, mais aussi les nécropoles et des espaces réservés à l’agriculture et aux pâturages. Le croisement des informations fournies par la topographie des tombes, leur typologie, leur mobilier, leur chronologie et
APA, Harvard, Vancouver, ISO, and other styles
5

SINGHAL, ESHAN, and ARPITA AGRAWAL. "AN ANALYSIS OF CONSTITUTIONAL AND LEGAL FRAMEWORK FOR OLD AGE PEOPLE IN INDIA." In THE BASIC TENETS OF LAW. Noble Science Press, 2022. http://dx.doi.org/10.52458/9789391842673.nsp2022.eb.asu.ch.05.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sinha, Arpit. "ASSESSMENT OF KNOWLEDGE, ATTITUDE AND PRACTICES REGARDING SEXUAL BEHAVIOUR AND HIV/AIDS AMONG IDU’S ENROLLED IN OST CENTRE, S.N. MEDICAL COLLEGE, AGRA." In STRATEGIES FOR ACHIEVING HEALTH AND HOSPITAL EXCELLENCE. NOBLE SCIENCE PRESS, 2024. http://dx.doi.org/10.52458/9788197040887.2024.eb.ch-03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Datey, Arpit. "COMPARISON OF KNOWLEDGE, ATTITUDE, AND PRACTICES OF MOBILE HEALTH TEAMS OF DISTRICT BURHANPUR AND KHANDWA POSTED UNDER RASHTRIYA BAL SWASTHYA KARYAKRAM IN MADHYA PRADESH." In APPROACHES TO HEALTH MANAGEMENT AND HOSPITAL MANAGEMENT. GRF Books, 2024. http://dx.doi.org/10.52458/9788196919580.2024.eb.ch-04.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

"Chapter 32. Arpit Gupta." In Fintech Founders. De Gruyter, 2019. http://dx.doi.org/10.1515/9781547401147-032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Garg, Arpit. "Foreword by Arpit Garg." In Understanding Insulin and Insulin Resistance. Elsevier, 2022. http://dx.doi.org/10.1016/b978-0-12-820234-0.00016-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

"Arpita Agnihotri Introduces Panel Data." In Understanding Panel Data with an Example from Studying Firm Ownership. SAGE Publications, Ltd., 2023. http://dx.doi.org/10.4135/9781529666670.n1.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Arpitā"

1

Ying, Haotian, Xinqi Feng, Qianya Lou, Lei Cai, and Xusheng Zhang. "Arpet: Using Virtual Pets to Facilitate F2F Social Communication in PAR." In 2024 17th International Symposium on Computational Intelligence and Design (ISCID). IEEE, 2024. https://doi.org/10.1109/iscid63852.2024.00051.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Meng, Yu, Kwei-Jay Lin, Bingnan Peng, Bolun Tsai, and Chih-Sheng Shih. "ArPico: Using Pictures to Build Localization Service for Indoor IoT Applications." In 2018 IEEE 11th Conference on Service-Oriented Computing and Applications (SOCA). IEEE, 2018. http://dx.doi.org/10.1109/soca.2018.00023.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Liu, Guangliang, Shigeng Zhang, Jianxin Wang, and Xuan Liu. "ArPat: Accurate RFID reader positioning with mere boundary tags." In 2014 20th IEEE International Conference on Parallel and Distributed Systems (ICPADS). IEEE, 2014. http://dx.doi.org/10.1109/padsw.2014.7097901.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Miao, Wenqiang, Chunhong Zhang, Zheng Hu, and Chenhe Zhang. "ARPIC: Personal Information Recognition of ID Card with Interference of Watermark." In 2021 7th International Conference on Computer and Communications (ICCC). IEEE, 2021. http://dx.doi.org/10.1109/iccc54389.2021.9674471.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sarmiento Calderón, Lucía Gabriela, and Leonardo Fabio Gómez Hormaza. "Arpi, a Social Robot for Children with Epilepsy." In HRI '23: ACM/IEEE International Conference on Human-Robot Interaction. ACM, 2023. http://dx.doi.org/10.1145/3568294.3580201.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jubrail, Jamil, Kshanti Africano Gomez, Floriane Herit, et al. "Human rhinovirus 16 infection of human macrophages disrupts Arpin expression impairing macrophage internalization: a potential link to exacerbation in chronic obstructive pulmonary disease?" In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.1063.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Arpitā"

1

Mosalam, Khalid, and Amarnath Kasalanati. PEER Activities 2018—2020. Pacific Earthquake Engineering Research Center, University of California, Berkeley, CA, 2020. http://dx.doi.org/10.55461/pwvt2699.

Full text
Abstract:
The Pacific Earthquake Engineering Research Center (PEER) is a multi-institutional research and education center with headquarters at the University of California, Berkeley. PEER’s mission is to (1) develop, validate, and disseminate performance-based engineering (PBE) technologies for buildings and infrastructure networks subjected to earthquakes and other natural hazards, with the goal of achieving community resilience; and (2) equip the earthquake engineering and other extreme-event communities with new tools. This report presents the activities of the Center over the period of July 1, 2018
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!